Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of the ChemiDoc MP Digital Imaging System. The imager combines the industry’s best performance with ease of use and is ideal ...
Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick ...
Oct 30 (Reuters) - Diagnostics firm Bio-Rad Laboratories (BIO.N), opens new tab posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical ...
Bio-Rad Laboratories BIO is something of a rarity: a small-cap company with a wide economic moat. The company develops products and solutions for the clinical diagnostics and life sciences industries, ...
Bio-Rad Laboratories is a life sciences company that manufactures clinical research and diagnostics products. The company's equity stake in Sartorius AG delivers a unique value proposition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback